Dr. Lanman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215
Education & Training
Massachusetts General HospitalFellowship, Neuro-Oncology, 2023 - 2025
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2020 - 2023
University of California San Diego School of MedicineClass of 2019
Certifications & Licensure
CA State Medical License 2022 - 2026
MA State Medical License 2023 - 2025
WA State Medical License 2025 - 2025
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 1 citationsIvosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.Tyler A Lanman, Gilbert Youssef, Raymond Huang, Rifaquat Rahman, Matthew DeSalvo
Neuro-Oncology Advances. 2024-12-19 - 2 citationsReady to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma.Tyler A Lanman, Toni Q Cao, Julie J Miller, Seema Nagpal
International Journal of Radiation Oncology, Biology, Physics. 2024-02-01 - A Single-Institution Retrospective Series of SARS-CoV-2 Infection in Adult Glioma Patients.Tyler Lanman, Amber N Ruiz, Seema Nagpal
Case Reports in Oncology. 2023-09-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
